| TTM
|
11/30/2025
|
11/30/2024
|
11/30/2023
|
11/30/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
8 | 8 | 1,249.8840 | 113.4130 | 15 |
|
Cost of Revenue
|
-- | -- | -- | 0 | 0 |
|
Gross Profit
|
8 | 8 | 1,249.8840 | 113.4130 | 15 |
| Selling, General and Administrative Expenses
|
-648.8260 | -312.9190 | -398.3550 | -415.0610 | -363.2680 |
|
Operating Income/Expenses
|
-648.8260 | -312.9190 | -398.3550 | -415.0610 | -363.2680 |
|
Total Operating Profit/Loss
|
-640.8260 | -304.9190 | 851.5290 | -301.6480 | -348.2680 |
| Total Net Finance Income/Expense
|
-13.1350 | -9.4960 | -1.9130 | 3.6760 | 5.2680 |
| Net Investment Income
|
-693.9790 | -693.9790 | -115.5240 | -122.3590 | -1,370.9210 |
| Irregular Income/Expenses
|
-6.6600 | -26.9370 | 0 | -80.0740 | 0 |
|
Non-Operating Income/Expenses, Total
|
-713.7740 | -730.4120 | -117.4370 | -198.7570 | -1,365.6530 |
|
Pretax Income
|
-1,354.6000 | -1,035.3310 | 734.0920 | -500.4050 | -1,713.9210 |
|
Provision for Income Tax
|
91.8870 | 91.8870 | -91.8870 | 0 | 0 |
|
Net Income from Continuing Operations
|
-1,262.7130 | -943.4440 | 642.2050 | -500.4050 | -1,713.9210 |
|
Discontinued Operations
|
103.5090 | -- | -- | -- | -- |
|
Other Net of Taxes Adjustments
|
0 | -- | -- | -- | -- |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-450.2570 | -943.4440 | 642.2050 | -500.4050 | -1,713.9210 |
|
Net Income after Non-Controlling/Minority Interests
|
-450.2570 | -943.4440 | 642.2050 | -500.4050 | -1,713.9210 |
|
Net Income Available to Common Stockholders
|
-450.2570 | -943.4440 | 642.2050 | -500.4050 | -1,713.9210 |
|
Diluted Net Income Available to Common Stockholders
|
-450.2570 | -943.4440 | 642.2050 | -500.4050 | -1,713.9210 |
| Basic EPS
|
-0.04 | -0.03 | 0.02 | -0.02 | -0.06 |
| Diluted EPS
|
-0.04 | -0.03 | 0.02 | -0.02 | -0.06 |
|
Basic Weighted Average Shares Outstanding
|
27,939.2600 | 27,939.2600 | 27,939.2600 | 27,939.2600 | 27,935.4640 |
|
Diluted Weighted Average Shares Outstanding
|
27,939.2600 | 27,939.2600 | 27,939.2600 | 27,939.2600 | 27,935.4640 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-1,341.4650 | -1,025.8350 | 736.0050 | -504.0810 | -1,719.1890 |
|
EBITDA
|
-1,341.4640 | -1,025.0190 | 740.8540 | -490.8480 | -1,712.8220 |
|
Normalized EBITDA
|
-1,334.8040 | -184.1030 | -171.5060 | -288.4150 | -341.9010 |
|
Normalized Income
|
-1,256.5048 | -177.1601 | -155.9540 | -297.9720 | -343 |
|
Total Unusual Items
|
6.6600 | 840.9160 | -912.3600 | 202.4330 | 1,370.9210 |
|
Total Unusual Items Excluding Goodwill
|
6.6600 | 840.9160 | -912.3600 | 202.4330 | 1,370.9210 |
11/30/2022 - 9/18/2009
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade